Outcome of Staph aureus Bacteremia Similar in Neutropenic and Non-Neutropenic Patients
June 8th 2018A prospective examination of over 2600 patients has not revealed a difference in their outcome compared with patients who are non-neutropenic when it comes to bacteremia caused by Staphylococcus aureus.
21st Century Cures Act Addresses Obstacles to Stopping Antibiotic Resistance
June 7th 2018A lack of coordination among regulating bodies, pharma manufacturers, standard development organizations, and laboratory testing device companies has muddied efforts to stop antibiotic resistance; the 21st Century Cures Act aims to fix that.
FDA Approves Biosimilar to Neulasta for the Prevention of Infection During Cancer Treatment
June 5th 2018Fulphila is the first biosimilar to Neulasta to decrease the chance of infection in patients with non-myeloid cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.